What’s still a bit murky is Doctronic’s accountability for mistakes. Normally, the doctor signing the scrip is responsible for any problems the patient has. Michelle Mello, a health law professor at Stanford University, said it’s unclear whether the company behind the AI will have the same responsibility.

“The courts have not worked that out, mostly because they have not been asked to yet,” Mello said. “We don’t have evidence of a lot of those kinds of claims percolating.”

Doctronic says it has a first-of-its-kind AI malpractice policy. Mello said while there’s a lot of uncertainty, most of the 190 medications the pilot covers are low risk. She does warn that it’s important to watch out for scope creep.

“Something I see is that we say ‘yes’ to a particular AI deployment,” she said. “And pretty quickly, we end up admitting a much larger presence of AI in healthcare than we originally envisioned.”

Expansion is already happening fast. Utah just gave the greenlight for another AI company — Legion Health — to renew some psychiatric medications. And Doctronic is in talks to move into Arizona and Wyoming.